Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Compass Pathways
CRO
Compass, Hackensack Meridian ink research deal for psilocybin
Compass Pathways inked a research collaboration deal with Hackensack Meridian Health for its investigational COMP360 psilocybin treatment.
Joseph Keenan
Jan 17, 2024 10:53am
Compass shows safety in first psilocybin trial for PTSD
Dec 20, 2023 7:26am
Data on psilocybin in anorexia point Compass to new opportunity
May 3, 2022 8:33am
Psilocybin clears biggest test yet, easing depression in phase 2
Nov 10, 2021 7:30am
Psychedelics inch toward approval, but market may not be ready
Aug 17, 2021 10:40am
Investors are tripping on psychedelics despite murky path ahead
Aug 16, 2021 9:50am